Contemporary treatment of in-stent restenosis and the incidence of recurrent in-stent restenosis in the era of drug-eluting stents

Andrew Edward Ajani, Bryan P Yan, David J Clark, David Eccleston, Anthony Walton, Robert M Lew, Adam David Meehan, Angela Leone Brennan, Christopher Michael Reid, Stephen J Duffy

Research output: Contribution to journalArticleResearchpeer-review

4 Citations (Scopus)


Background:Optimal treatment of in-stent restenosis (ISR) remains uncertain in the era of drug-eluting stents (DES). This study aims to determine contemporary treatment of ISR and to assess recurrent ISR rates in the era of DES. Methods: We examined 60 patients presenting for treatment of ISR (one lesion per patient) who were enrolled in the Melbourne Interventional Group Registry (4 of total population of 1423 patients) between April 2004 and January 2005. Twelve-month follow-up is complete for all patients. Results: The majority of ISR treated occurred in bare metal stents [BMS (n = 52, 87 )] and had a focal (
Original languageEnglish
Pages (from-to)269 - 273
Number of pages5
JournalHeart Lung and Circulation
Issue number4
Publication statusPublished - 2007

Cite this